Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Verastem (VSTM) Operating Expenses: 2018-2025

Historic Operating Expenses for Verastem (VSTM) over the last 8 years, with Sep 2025 value amounting to $52.0 million.

  • Verastem's Operating Expenses rose 40.31% to $52.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $173.6 million, marking a year-over-year increase of 51.40%. This contributed to the annual value of $125.0 million for FY2024, which is 35.70% up from last year.
  • Latest data reveals that Verastem reported Operating Expenses of $52.0 million as of Q3 2025, which was up 13.19% from $45.9 million recorded in Q2 2025.
  • In the past 5 years, Verastem's Operating Expenses ranged from a high of $52.0 million in Q3 2025 and a low of $14.8 million during Q3 2021.
  • Moreover, its 3-year median value for Operating Expenses was $29.9 million (2024), whereas its average is $32.8 million.
  • Per our database at Business Quant, Verastem's Operating Expenses slumped by 76.67% in 2021 and then spiked by 73.78% in 2024.
  • Verastem's Operating Expenses (Quarterly) stood at $17.1 million in 2021, then dropped by 1.23% to $16.8 million in 2022, then increased by 20.33% to $21.3 million in 2023, then skyrocketed by 73.78% to $31.6 million in 2024, then soared by 40.31% to $52.0 million in 2025.
  • Its Operating Expenses was $52.0 million in Q3 2025, compared to $45.9 million in Q2 2025 and $44.2 million in Q1 2025.